Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Probability of Starting Two-Drug Regimen (2DR) vs. Three-Drug Regimen (3DR) in ART-Naïve and ART-Experienced Person with HIV (PWH) Across the First Wave of COVID-19 Pandemic.
Vergori A, Gianotti N, Tavelli A, Tincati C, Giacomelli A, Matteini E, Lapadula G, Taramasso L, Sarmati L, D'Arminio Monforte A, Antinori A, Cozzi-Lepri A, On Behalf Of The Icona Foundation Study; ICONA Foundation Study. Vergori A, et al. Among authors: gianotti n. Viruses. 2024 Nov 23;16(12):1822. doi: 10.3390/v16121822. Viruses. 2024. PMID: 39772133 Free PMC article.
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life setting.
Papaioannu Borjesson R, Clemente T, Diotallevi S, Lolatto R, Forniti A, Bottanelli M, Galli L, Gianotti N, Muccini C, Hasson H, Castagna A, Spagnuolo V. Papaioannu Borjesson R, et al. Among authors: gianotti n. J Antimicrob Chemother. 2024 Nov 21:dkae420. doi: 10.1093/jac/dkae420. Online ahead of print. J Antimicrob Chemother. 2024. PMID: 39568118
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians' and nurses' points of view.
Cingolani A, Tavelli A, De Benedittis S, Mastrorosa I, Muccini C, Bini T, Carraro A, Compagno M, Mazzitelli M, Guastavigna M, Cernuschi M, Torti C, Antinori A, d'Arminio Monforte A; ICONA Foundation Study group. Cingolani A, et al. J Antimicrob Chemother. 2024 Oct 1;79(10):2662-2667. doi: 10.1093/jac/dkae273. J Antimicrob Chemother. 2024. PMID: 39140512
One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study.
Muccini C, Gianotti N, Diotallevi S, Lolatto R, Spagnuolo V, Canetti D, Bagaglio S, Perez VG, Clemente T, Bottanelli M, Candela C, Nozza S, Castagna A. Muccini C, et al. Among authors: gianotti n. Open Forum Infect Dis. 2024 Jun 20;11(7):ofae326. doi: 10.1093/ofid/ofae326. eCollection 2024 Jul. Open Forum Infect Dis. 2024. PMID: 38962526 Free PMC article.
Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration.
Tusch E, Ryom L, Pelchen-Matthews A, Mocroft A, Elbirt D, Oprea C, Günthard HF, Staehelin C, Zangerle R, Suarez I, Vehreschild JJ, Wit F, Menozzi M, d'Arminio Monforte A, Spagnuolo V, Pradier C, Carlander C, Suanzes P, Wasmuth JC, Carr A, Petoumenos K, Borgans F, Bonnet F, De Wit S, El-Sadr W, Neesgaard B, Jaschinski N, Greenberg L, Hosein SR, Gallant J, Vannappagari V, Young L, Sabin C, Lundgren J, Peters L, Reekie J; D:A:D cohort study; RESPOND cohort study. Tusch E, et al. Clin Infect Dis. 2024 Nov 22;79(5):1242-1257. doi: 10.1093/cid/ciae228. Clin Infect Dis. 2024. PMID: 38663013
274 results